biobanking | GenomeWeb

biobanking

Mount Sinai is the latest healthcare provider to link up with Regeneron's Genetics Center, to pair NGS data with electronic medical record data.

The biobank will also provide lab services to researchers, academic institutions, pharmaceutical firms, and contract research organizations worldwide.

Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.

PNRI researchers will be able to analyze information from over 600,000 discrete tumor, blood, and urine samples from around 25,000 patients.

The Human Cancer Models Initiative aims to create about 1,000 cancer cell lines that scientists can use to study tumor progression, drug resistance, and more.

The agency said it would disperse the funds to the clinic over the course of five years to collect, store, and distribute biospecimens for precision medicine research.

The healthcare provider plans to build a large biobank to conduct precision medicine research based on genomics, lifestyle, and environmental factors. 

Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.

While the new methods were developed specifically to address the UKBB's needs, Affymetrix believes the approaches will set a precedent for industrial-scale genotyping.

Researchers are combining identity-by-descent-based ancestry information with electronic health records and self-reported ancestry information for thousands of New Yorkers. 

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.